Our history
It determines us to be tireless in moving towards the FUTURE.
1998
Foundation
ROXALL Group
ROXALL Medizin was founded in Hamburg, Germany, with extensive knowledge in the field of immunotherapy.
2008
Foundation
ROXALL Turkey
ROXALL Medizin expands its borders with its first subsidiary in Turkey.
2010
Foundation
ROXALL Austria
ROXALL Medizin begins its expansion process in Austria. Evolution to the ROXALL Group.
2011
Foundation
ROXALL Italia
Italy has become a new home for the ROXALL Group in the marketing of immunotherapy products.
2017
Foundation
ROXALL España
Acquisition of the allergy line in Bilbao, Spain (BIAL Aristegui). A solid foundation for current and future growth.
Immunotherapy research has been the main objective of this site for over 70 years.
2021
Expansion
ROXALL future
Process of expansion outside Europe.
Key markets: Eurasia and Latin America.
2026
Positioning
We have reaffirmed our position in all our facilities. We have maintained our growth in each of our subsidiaries.
Our goal: to maintain our distinctive R&D and precision immunotherapy while looking to the FUTURE.
